Forthcoming

The Outer Life of Prozac

Depression and Technoscience

Authors

Keywords:

depression, antidepressants, serotonin, psychopharmaceuticals, technoscience

Abstract

Over the second half of the 20th century, our experience and understanding of the affective domain have changed profoundly. Regarding negative feelings, a key point has been the rise of the category of depression. This article examines part of this history to argue for an understanding of depression as a category of technoscience, thus exploring some of epistemological and political problems that this implies. In order to analyze the role played by the development, commodification and consumption of antidepressants in the expansion of the diagnostic category of depression, the article works with the idea of an “outer life” of pills. This notion seeks to bring together, on the one hand, a consideration of the commodified and sociocultural circulation of antidepressants and, on the other hand, an emphasis on their material effects, understood however as inseparable from such circulation. With a critical and interdisciplinary approach, and drawing on insights and debates from new materialisms and science studies, this article aims to intervene in complex current controversies about depression and antidepressants, highlighting the inseparability of biology and politics in contemporary discussions about distress and its treatments.

Downloads

Download data is not yet available.

Author Biography

Renata Prati, Universidad de Buenos Aires

PhD in philosophy and specialist in literary translation, University of Buenos Aires (UBA), Argentina.

References

Aftab, A. (2022). The Case for Antidepressants in 2022. Psychiatry at the Margins. Recuperado de: awaisaftab.substack.com/p/the-case-forantidepressants-in-2022.

Appadurai, A. (1991). La vida social de las cosas. Perspectiva cultural de las Mercancías. México: Grijalbo.

Barad, K. (2008). Posthumanist Performativity: Toward an Understanding of How Matter Comes to Matter. En S. Alaimo & S. J. Hekman (Eds.), Material Feminisms. Bloomington: Indiana University Press.

Becker, H. (2016). Cómo fumar marihuana y tener un buen viaje. Una mirada sociológica. Buenos Aires: Siglo XXI.

Bennett, J. (2022). Materia vibrante. Una ecología política de las cosas. Buenos Aires: Caja Negra.

Cecchi, H. (2001). Una noticia para comerse las uñas. Página/12, 16 de agosto. Recuperado de: https://www.pagina12.com.ar/2001/01-08/01-08-16/pag19.htm

Clarke, A. E., Mamo, L., Fishman, J. R., Shim, J. K. & Fosket, J. R. (2003). Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine. American Sociological Review, 68(2), 161.

Cuthbertson, C. (2015). Pharmaceutical Technologies and the Management of Biological Citizens in Chile. En S. E. Bell & A. E. Figert (Eds.), Reimagining (Bio)medicalization, Pharmaceuticals and Genetics. Old Critiques and New Engagements. Nueva York: Routledge.

Cvetkovich, A. (2012). Depression. A Public Feeling. Durham & Londres: Duke University Press.

Dumit, J. (2000). When Explanations Rest: “Good-enough” Brain Science and the New Socio-medical Disorders. En M. Lock, A. Young & A. Cambrosio (Eds.), Living and Working with the New Medical Technologies (209-232). Cambridge: Cambridge University Press.

Dumit, J. (2003). Is It Me or My Brain? Depression and Neuroscientific Facts. Journal of Medical Humanities, 24(1/2), 35-47.

Dumit, J. (2004). Picturing Personhood. Brain Scans and Biomedical Identity. Princeton: Princeton University Press.

Dupré, J. (2002). Human Nature and the Limits of Science. Oxford: Oxford University Press.

Foucault, M. (1996). La vida de los hombres infames. Ensayos sobre desviación y dominación. Buenos Aires: Altamira.

France, C. M., Lysaker, P. H. & Robinson, R. P. (2007). The “Chemical Imbalance” Explanation for Depression: Origins, Lay Endorsement, and Clinical Implications. Professional Psychology: Research and Practice, 38(4), 411-420.

Fraser, M. (2001). The Nature of Prozac. History of the Human Sciences, 14(3), 56-84.

Fraser, M. (2003). Material Theory: Duration and the Serotonin Hypothesis of Depression. Theory, Culture & Society, 20(5), 1-26.

Gardner, P. (2003). Distorted Packaging: Marketing Depression as Illness, Drugs as Cure. Journal of Medical Humanities, 24(1/2), 105-130.

Gill-Peterson, J. (2016). Neurofeminism. En V. Pitts-Taylor (Ed.), Mattering (188-203). Nueva York: New York University Press.

Haraway, D. J. (1995). Ciencia, cyborgs y mujeres. Madrid: Cátedra.

Haraway, D. J. (2021). Testigo_Modesto@Segundo_Milenio. HombreHembra©_Conoce_OncoRata®. Feminismo y tecnociencia. Buenos Aires: Rara Avis.

Harrington, A. (2019). Mind Fixers. Psychiatry’s Troubled Search for the Biology of Mentall Illness. Nueva York: W. W. Norton.

Healy, D. (1997). The Antidepressant Era. Cambridge: Harvard University Press.

Hengartner, M. P. & Plöderl, M. (2018). Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter! Frontiers in Psychiatry, 9.

Hirshbein, L. D. (2009). American Melancholy. Constructions of Depression in the Twentieth Century. Nueva Brunswick & Londres: Rutgers University Press.

Karp, D. A. (2017). Speaking of Sadness. Depression, Disconnection, and the Meanings of Illness. Oxford: Oxford University Press.

Kramer, P. D. (1994). Escuchando al Prozac. Un psiquiatra explora el campo de los antidepresivos. Barcelona: Seix Barral.

Kramer, P. D. (2006). Contra la depresión. Barcelona: Seix Barral.

Lacasse, J. R. & Leo, J. (2005). Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature. PLoS Medicine, 2(12), e392.

Lakoff, A. (2005). Pharmaceutical Reason. Knowledge and Value in Global Psychiatry. Cambridge: Cambridge University Press.

Latour, B. (2022). Pasteur: Guerra y paz de los microbios, seguido de Irreducciones. Buenos Aires: Isla Desierta.

Lewis, B. (2006). Moving Beyond Prozac, DSM, & the New Psychiatry. The Birth of Postpsychiatry. Ann Arbor: University of Michigan Press.

Morozov, E. (2015). La locura del solucionismo tecnológico. Madrid & Buenos Aires: Katz.

Pignarre, P. (2012). Comment la dépression est devenue une épidémie. París: La Découverte.

Rose, N. (2012). Políticas de la vida. Biomedicina, poder y subjetividad en el siglo XXI. Buenos Aires: UNIPE.

Rose, N. & Abi-Rached, J. M. (2013). Neuro. The New Brain Sciences and the Management of the Mind. Princeton: Princeton University Press.

Sadowsky, J. H. (2021). The Empire of Depression. A New History. Cambridge: Polity.

Sánchez, A. (2021). Fármaco. Buenos Aires: Odelia.

Slaby, J. & Gallagher, S. (2015). Critical Neuroscience and Socially Extended Minds. Theory, Culture & Society, 32(1), 33-59.

Solana, M. (2017). “Relatos sobre el surgimiento del giro afectivo y el nuevo materialismo: ¿está agotado el giro lingüístico?”. Cuadernos de Filosofía, 69, 87-103.

Time (1952). Medicine: TB and Hope. Time, 3 de marzo. Recuperado de: https://content.time.com/time/subscriber/article/0,33009,890255,00.html.

Vidal, F. & Ortega, F. (2012). Are there Neural Correlates of Depression? En S. Choudhury & J. Slaby (Eds.), Critical Neuroscience. A Handbook of the Social and Cultural Contexts of Neuroscience. Chichester: Wiley Blackwell.

Wilson, E. A. (2021). Feminismo de las tripas. Buenos Aires: Club Hem.

Downloads

Published

2023-12-20

How to Cite

Prati, R. (2023). The Outer Life of Prozac: Depression and Technoscience. Revista Iberoamericana De Ciencia, Tecnología Y Sociedad - CTS (Ibero-American Science, Technology and Society Journal). Retrieved from https://ojs.revistacts.net/index.php/CTS/article/view/441

Issue

Section

Articles